학술논문
Quantitative HBsAg an unreliable marker for diagnosis and disease progression in genotype F chronic HBeAg‐negative infections.
Document Type
Article
Author
Source
Subject
*DIAGNOSIS
*DISEASE progression
*GENOTYPES
*HEPATITIS B
*
*
*
Language
ISSN
1352-0504
Abstract
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype. Keywords: biomarkers; HBV-DNA; hepatitis B virus; liver disease; pathogenesis EN biomarkers HBV-DNA hepatitis B virus liver disease pathogenesis 298 301 4 03/15/22 20220401 NES 220401 INTRODUCTION The HBeAg-negative stage represents a late phase in the natural course of chronic hepatitis B virus (HBV) infection.1 This phase includes two settings, on the one hand chronic HBeAg-negative infection (ENI), characterized by persistently normal ALT levels, low HBV-DNA titers, and usually associated with a benign non-progressive infection. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. [Extracted from the article]